Circulating CD34+, CD133+, and Vascular Endothelial Growth Factor Receptor 2–Positive Endothelial Progenitor Cells in Myelofibrosis With Myeloid Metaplasia
Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.09.021
Full Text
Open PDFAbstract
Available in full text
Date
August 20, 2005
Authors
Publisher
American Society of Clinical Oncology (ASCO)